Metabolic engineering of a carbapenem antibiotic synthesis pathway in Escherichia coli

Nature Chemical Biology

Volumn 14, Issue 8, 2018, Pages 794-800

  Shomar, Helena ^a   Gontier, Sophie ^b   Van Den Broek, Niels J F ^a   Tejeda Mora, Héctor ^a   Noga, Marek J ^a   Hagedoorn, Peter Leon ^c   Bokinsky, Gregory ^a  

^a DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

^b Franceantoinemariesci gmailcomhttps: antoinemariesciwixsitecom antoinemarie   (France)

^c DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM DERIVATIVE; FATTY ACID; HYDROXYLAMINE; IMIPENEM; PROLINE DEHYDROGENASE;

ANTIBIOTIC THERAPY; ARTICLE; DRUG SYNTHESIS; ESCHERICHIA COLI; FATTY ACID SYNTHESIS; MEMBRANE PERMEABILITY; METABOLIC ENGINEERING; MICROBIAL DIVERSITY; NONHUMAN; PECTOBACTERIUM CAROTOVORUM; PRIORITY JOURNAL; STREPTOMYCES; BIOSYNTHESIS; CHEMISTRY; METABOLISM;

CARBAPENEMS; ESCHERICHIA COLI; METABOLIC ENGINEERING;

EID: 85048962896     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/s41589-018-0084-6     Document Type: Article

References (56)

1. Gillespie, D. E. et al. Isolation of antibiotics turbomycin a and B from a metagenomic library of soil microbial DNA. Appl. Environ. Microbiol. 68, 4301-4306 (2002).
2. Ling, L. L. et al. A new antibiotic kills pathogens without detectable resistance. Nature 517, 455-459 (2015).
3. Rutledge, P. J. &Challis, G. L. Discovery of microbial natural products by activation of silent biosynthetic gene clusters. Nat. Rev. Microbiol. 13, 509-523 (2015).
4. Brady, S. F., Simmons, L., Kim, J. H. &Schmidt, E. W. Metagenomic approaches to natural products from free-living and symbiotic organisms. Nat. Prod. Rep. 26, 1488-1503 (2009).
5. Olano, C., Lombó, F., Méndez, C. &Salas, J. A. Improving production of bioactive secondary metabolites in actinomycetes by metabolic engineering. Metab. Eng. 10, 281-292 (2008).
6. Katz, L. &Khosla, C. Antibiotic production from the ground up. Nat. Biotechnol. 25, 428-429 (2007).
7. Demain, A. L. From natural products discovery to commercialization: a success story. J. Ind. Microbiol. Biotechnol. 33, 486-495 (2006).
8. Medema, M. H., Breitling, R., Bovenberg, R. &Takano, E. Exploiting plug-and-play synthetic biology for drug discovery and production in microorganisms. Nat. Rev. Microbiol. 9, 131-137 (2011).
9. Awan, A. R. et al. Biosynthesis of the antibiotic nonribosomal peptide penicillin in baker's yeast. Nat. Commun. 8, 15202 (2017).
10. Freeman, M. F., Vagstad, A. L. &Piel, J. Polytheonamide biosynthesis showcasing the metabolic potential of sponge-associated uncultivated 'Entotheonella' bacteria. Curr. Opin. Chem. Biol. 31, 8-14 (2016).
11. Hamed, R. B., Henry, L., Claridge, T. D. W. &Schofield, C. J. Stereoselective production of dimethyl-substituted carbapenams via engineered carbapenem biosynthesis enzymes. ACS Catal. 7, 1279-1285 (2017).
12. Zhang, H., Wang, Y., Wu, J., Skalina, K. &Pfeifer, B. A. Complete biosynthesis of erythromycin A and designed analogs using E. coli as a heterologous host. Chem. Biol. 17, 1232-1240 (2010).
13. McKenna, M. Antibiotic resistance: the last resort. Nature 499, 394-396 (2013).
14. Papp-Wallace, K. M., Endimiani, A., Taracila, M. A. &Bonomo, R. A. Carbapenems: past, present, and future. Antimicrob. Agents Chemother. 55, 4943-4960 (2011).
15. Wei, W. J., Yang, H. F., Ye, Y. &Li, J. B. Bin. New Delhi metallo-betalactamase-mediated carbapenem resistance: Origin, diagnosis, treatment and public health concern. Chin. Med. J. (Engl.) 128, 1969-1976 (2015).
16. Kahan, J. S. et al. Thienamycin, a new beta-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties. J. Antibiot. (Tokyo) 32, 1-12 (1979).
17. Hamed, R. B. et al. The enzymes of β-lactam biosynthesis. Nat. Prod. Rep. 30, 21-107 (2013).
18. Coulthurst, S. J., Barnard, A. M. L. &Salmond, G. P. C. Regulation and biosynthesis of carbapenem antibiotics in bacteria. Nat. Rev. Microbiol. 3, 295-306 (2005).
19. McGowan, S. J. et al. Analysis of bacterial carbapenem antibiotic production genes reveals a novel beta-lactam biosynthesis pathway. Mol. Microbiol. 22, 415-426 (1996).
20. Pfaendler, H. R., Gosteli, J., Woodward, R. B. &Rihs, G. Structure, reactivity, and biological activity of strained bicyclic β-lactams. J. Am. Chem. Soc. 103, 4526-4531 (1981).
21. McGowan, S. J. et al. Analysis of the carbapenem gene cluster of Erwinia carotovora: definition of the antibiotic biosynthetic genes and evidence for a novel β-lactam resistance mechanism. Mol. Microbiol. 26, 545-556 (1997).
22. van Vugt-Lussenburg, B. M., van der Weel, L., Hagen, W. R. &Hagedoorn, P. L. Biochemical similarities and differences between the catalytic [4Fe-4S] cluster containing fumarases FumA and FumB from Escherichia coli. PLoS One 8, e55549 (2013).
23. McHugh, J. P. et al. Global iron-dependent gene regulation in Escherichia coli. A new mechanism for iron homeostasis. J. Biol. Chem. 278, 29478-29486 (2003).
24. Stiefel, E. I. &George, G. N. in Bioinorganic Chemistry (eds. Bertini, I., Gray, H.B., Lippard, S.J. &Valentine, J.S.) Ch. 7 (University Science Books, Mill Valley, CA, 1994).
25. Altschul, S. F., Gish, W., Miller, W., Myers, E. W. &Lipman, D. J. Basic local alignment search tool. J. Mol. Biol. 215, 403-410 (1990).
26. Gerratana, B., Stapon, A. &Townsend, C. A. Inhibition and alternate substrate studies on the mechanism of carbapenam synthetase from Erwinia carotovora. Biochemistry 42, 7836-7847 (2003).
27. Stapon, A., Li, R. &Townsend, C. A. Carbapenem biosynthesis: confirmation of stereochemical assignments and the role of CarC in the ring stereoinversion process from L-proline. J. Am. Chem. Soc. 125, 8486-8493 (2003).
28. Chang, W. C. et al. Mechanism of the C5 stereoinversion reaction in the biosynthesis of carbapenem antibiotics. Science 343, 1140-1144 (2014).
29. Pérez-Arellano, I., Carmona-Álvarez, F., Gallego, J. &Cervera, J. Molecular mechanisms modulating glutamate kinase activity. Identification of the proline feedback inhibitor binding site. J. Mol. Biol. 404, 890-901 (2010).
30. Korch, S. B. &Hill, T. M. Ectopic overexpression of wild-type and mutant hipA genes in Escherichia coli: effects on macromolecular synthesis and persister formation. J. Bacteriol. 188, 3826-3836 (2006).
31. Bokinsky, G. et al. HipA-triggered growth arrest and β-lactam tolerance in Escherichia coli are mediated by RelA-dependent ppGpp synthesis. J. Bacteriol. 195, 3173-3182 (2013).
32. Heath, R. J., Jackowski, S. &Rock, C. O. Guanosine tetraphosphate inhibition of fatty acid and phospholipid synthesis in Escherichia coli is relieved by overexpression of glycerol-3-phosphate acyltransferase (plsB). J. Biol. Chem. 269, 26584-26590 (1994).
33. Rodionov, D. G. &Ishiguro, E. E. Dependence of peptidoglycan metabolism on phospholipid synthesis during growth of Escherichia coli. Microbiology 142, 2871-2877 (1996).
34. Omura, S. The antibiotic cerulenin, a novel tool for biochemistry as an inhibitor of fatty acid synthesis. Bacteriol. Rev. 40, 681-697 (1976).
35. Rogers, J. K. &Church, G. M. Genetically encoded sensors enable real-time observation of metabolite production. Proc. Natl Acad. Sci. USA 113, 2388-2393 (2016).
36. Yang, Y., Lin, Y., Li, L., Linhardt, R. J. &Yan, Y. Regulating malonyl-CoA metabolism via synthetic antisense RNAs for enhanced biosynthesis of natural products. Metab. Eng. 29, 217-226 (2015).
37. Fehér, T., Libis, V., Carbonell, P. &Faulon, J.-L. A sense of balance: experimental investigation and modeling of a malonyl-CoA sensor in Escherichia coli. Front. Bioeng. Biotechnol. 3, 46 (2015).
38. Cameron, D. E. &Collins, J. J. Tunable protein degradation in bacteria. Nat. Biotechnol. 32, 1276-1281 (2014).
39. Rosi, D. et al. Mutants of Streptomyces cattleya producing N-acetyl and deshydroxy carbapenems related to thienamycin. J. Antibiot. (Tokyo) 34, 341-343 (1981).
40. Wilson, K. E., Kempf, A. J., Liesch, J. M. &Arison, B. H. Northienamycin and 8-epi-thienamycin, new carbapenems from Streptomyces cattleya. J. Antibiot. (Tokyo) 36, 1109-1117 (1983).
41. Wagman, G. H. &Cooper, R. Natural Products Isolation: Separation Methods for Antimicrobials, Antivirals and Enzyme Inhibitors (Elsevier Science, New York, 1988).
42. Bateson, J. H., Baxter, A. J. G., Roberts, P. M., Smale, T. C. &South-Gate, R. Olivanic acid analogues. Part 1. Total synthesis of the 7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate system and some related β-lactams. J. Chem. Soc. Perkin Trans. I 1981, 3242-3249 (1981).
43. Zabala, D., Braña, A. F., Flórez, A. B., Salas, J. A. &Méndez, C. Engineering precursor metabolite pools for increasing production of antitumor mithramycins in Streptomyces argillaceus. Metab. Eng. 20, 187-197 (2013).
44. Gómez, C. et al. Amino acid precursor supply in the biosynthesis of the RNA polymerase inhibitor streptolydigin by Streptomyces lydicus. J. Bacteriol. 193, 4214-4223 (2011).
45. Zhang, M. M., Wang, Y., Ang, E. L. &Zhao, H. Engineering microbial hosts for production of bacterial natural products. Nat. Prod. Rep. 33, 963-987 (2016).
46. Marous, D. R. et al. Consecutive radical S-adenosylmethionine methylations form the ethyl side chain in thienamycin biosynthesis. Proc. Natl Acad. Sci. USA 112, 10354-10358 (2015).
47. Kirby, J. et al. Engineering a functional 1-deoxy-d-xylulose 5-phosphate (DXP) pathway in Saccharomyces cerevisiae. Metab. Eng. 38, 494-503 (2016).
48. Tuomanen, E. Phenotypic tolerance: the search for β-lactam antibiotics that kill nongrowing bacteria. Rev. Infect. Dis. 8 (Suppl. 3), S279-S291 (1986).
49. Briand, L. et al. A self-inducible heterologous protein expression system in Escherichia coli. Sci. Rep. 6, 33037 (2016).
50. Neidhardt, F. C., Bloch, P. L. &Smith, D. F. Culture medium for enterobacteria. J. Bacteriol. 119, 736-747 (1974).
51. Gibson, D. G. et al. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat. Methods 6, 343-345 (2009).
52. Lee, T. S. et al. BglBrick vectors and datasheets: A synthetic biology platform for gene expression. J. Biol. Eng. 5, 12 (2011).
53. Hagen, W. R. Biomolecular EPR Spectroscopy. CRC Press. (CRC Press, Boca Raton, 2008).
54. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254 (1976).
55. Datsenko, K. A. &Wanner, B. L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl Acad. Sci. USA 97, 6640-6645 (2000).
56. Parker, W. L. et al. SQ 27,860, a simple carbapenem produced by species of Serratia and Erwinia. J. Antibiot. (Tokyo) 35, 653-660 (1982).